Firmaet har fremlagt oplysninger, der viser, at denne patientgruppe ikke er så uensartet, men i vidt omfang svarer til hele populationen i EUROPA- undersøgelsen, i hvert fald hvad angår revaskulariseringsteknik og ledsagende behandling.
The Company has provided data showing that this population is not so heterogeneous but quite similar to the whole population included in EUROPE study, at least in terms of revascularisation techniques and concomitant treatments.